These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30249452)

  • 1. CD8
    Kleczko EK; Marsh KH; Tyler LC; Furgeson SB; Bullock BL; Altmann CJ; Miyazaki M; Gitomer BY; Harris PC; Weiser-Evans MCM; Chonchol MB; Clambey ET; Nemenoff RA; Hopp K
    Kidney Int; 2018 Dec; 94(6):1127-1140. PubMed ID: 30249452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
    Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.
    Hopp K; Kleczko EK; Gitomer BY; Chonchol M; Klawitter J; Christians U; Klawitter J
    Am J Physiol Renal Physiol; 2022 Mar; 322(3):F258-F267. PubMed ID: 35037466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
    Trant J; Sanchez G; McDermott JP; Blanco G
    Am J Physiol Renal Physiol; 2023 Dec; 325(6):F857-F869. PubMed ID: 37823195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
    Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models.
    Zhang X; Li LX; Ding H; Torres VE; Yu C; Li X
    J Am Soc Nephrol; 2021 Nov; 32(11):2759-2776. PubMed ID: 34716241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nedd9 restrains renal cystogenesis in Pkd1-/- mice.
    Nikonova AS; Plotnikova OV; Serzhanova V; Efimov A; Bogush I; Cai KQ; Hensley HH; Egleston BL; Klein-Szanto A; Seeger-Nukpezah T; Golemis EA
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12859-64. PubMed ID: 25139996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Viau A; Baaziz M; Aka A; Mazloum M; Nguyen C; Kuehn EW; Terzi F; Bienaimé F
    J Am Soc Nephrol; 2020 May; 31(5):1035-1049. PubMed ID: 32238474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.
    Hopp K; Hommerding CJ; Wang X; Ye H; Harris PC; Torres VE
    J Am Soc Nephrol; 2015 Jan; 26(1):39-47. PubMed ID: 24994926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.
    Leonhard WN; Zandbergen M; Veraar K; van den Berg S; van der Weerd L; Breuning M; de Heer E; Peters DJ
    J Am Soc Nephrol; 2015 Jun; 26(6):1322-33. PubMed ID: 25361818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
    Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
    Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.
    Wang E; Hsieh-Li HM; Chiou YY; Chien YL; Ho HH; Chin HJ; Wang CK; Liang SC; Jiang ST
    J Pathol; 2010 Nov; 222(3):238-48. PubMed ID: 20814903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report.
    Gonda K; Akama T; Nakamura T; Hashimoto E; Kyoya N; Rokkaku Y; Maejima Y; Horita S; Tachibana K; Abe N; Ohtake T; Shimomura K; Kono K; Saji S; Takenoshita S; Higashihara E
    J Med Case Rep; 2019 Dec; 13(1):381. PubMed ID: 31870441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
    Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease.
    Arkhipov SN; Potter DL; Sultanova RF; Ilatovskaya DV; Harris PC; Pavlov TS
    Physiol Rep; 2023 Apr; 11(7):e15652. PubMed ID: 37024297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyst expansion and regression in a mouse model of polycystic kidney disease.
    Happé H; van der Wal AM; Salvatori DC; Leonhard WN; Breuning MH; de Heer E; Peters DJ
    Kidney Int; 2013 Jun; 83(6):1099-108. PubMed ID: 23466997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint activity regulates polycystic kidney disease progression.
    Kleczko EK; Nguyen DT; Marsh KH; Bauer CD; Li AS; Monaghan MT; Berger MD; Furgeson SB; Gitomer BY; Chonchol MB; Clambey ET; Zimmerman KA; Nemenoff RA; Hopp K
    JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37345660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.